Next we examined atypical CD19 + IgD− CD27-B cells, termed double-negative (DN), which have been implicated in the pathogenesis of a range of diseases, including responses to COVID-19 infection, certain cancers, chronic inflammatory disorders, and autoimmune diseases35. This evidence concerns the gene CD19 and cancer.